Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.

Labourier E, Shifrin A, Busseniers AE, Lupo MA, Manganelli ML, Andruss B, Wylie D, Beaudenon-Huibregtse S.

J Clin Endocrinol Metab. 2015 Jul;100(7):2743-50. doi: 10.1210/jc.2015-1158. Epub 2015 May 12.

2.

Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.

Griffiths M, Patton SJ, Grossi A, Clark J, Paz MF, Labourier E; Labceutics International BCR-ABL1 Standardization Study Group.

Arch Pathol Lab Med. 2015 Apr;139(4):522-9. doi: 10.5858/arpa.2013-0754-OA. Epub 2014 Jul 25.

PMID:
25061833
3.

Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens.

Giordano TJ, Beaudenon-Huibregtse S, Shinde R, Langfield L, Vinco M, Laosinchai-Wolf W, Labourier E.

Hum Pathol. 2014 Jul;45(7):1339-47. doi: 10.1016/j.humpath.2014.03.010. Epub 2014 Apr 4.

PMID:
24830619
4.

Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.

Beaudenon-Huibregtse S, Alexander EK, Guttler RB, Hershman JM, Babu V, Blevins TC, Moore P, Andruss B, Labourier E.

Thyroid. 2014 Oct;24(10):1479-87. doi: 10.1089/thy.2013.0640. Epub 2014 Jun 18.

PMID:
24811481
5.

A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.

Brand RE, Adai AT, Centeno BA, Lee LS, Rateb G, Vignesh S, Menard C, Wiechowska-Kozłowska A, Bołdys H, Hartleb M, Sanders MK, Munding JB, Tannapfel A, Hahn SA, Stefańczyk L, Tsongalis GJ, Whitcomb DC, Conwell DL, Morisset JA, Gardner TB, Gordon SR, Suriawinata AA, Lloyd MB, Wylie D, Labourier E, Andruss BF, Szafranska-Schwarzbach AE.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1717-23. doi: 10.1016/j.cgh.2014.02.038. Epub 2014 Mar 21.

PMID:
24662333
6.

A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens.

Smith DL, Lamy A, Beaudenon-Huibregtse S, Sesboüé R, Laosinchai-Wolf W, Sabourin JC, Labourier E.

Arch Pathol Lab Med. 2014 Mar;138(3):371-8. doi: 10.5858/arpa.2013-0002-OA. Epub 2013 Jun 28.

PMID:
23808402
7.

Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.

White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E.

Clin Chem. 2013 Jun;59(6):938-48. doi: 10.1373/clinchem.2012.196477. Epub 2013 Mar 7.

8.

Do pre-analytical parameters explain KRAS test sensitivity disparities?

Labourier E.

J Mol Diagn. 2012 Nov;14(6):631-3; author reply 632-3. doi: 10.1016/j.jmoldx.2012.07.003. No abstract available.

9.

An optimized technology platform for the rapid multiplex molecular analysis of genetic alterations associated with leukemia.

Ye F, Laosinchai-Wolf W, Labourier E.

Cancer Genet. 2012 Oct;205(10):488-500. doi: 10.1016/j.cancergen.2012.06.006. Epub 2012 Sep 29.

10.

Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: results from a multicenter validation study.

Gocke CD, Mason J, Brusca L, Laosinchai-Wolf W, Higgs C, Newell H, Masters A, Friar L, Karp J, Griffiths M, Wei Q, Labourier E.

Blood Cancer J. 2012 Jul;2(7):e78. doi: 10.1038/bcj.2012.24. Epub 2012 Jul 13.

11.

Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages.

Rangel-Salazar R, Wickström-Lindholm M, Aguilar-Salinas CA, Alvarado-Caudillo Y, Døssing KB, Esteller M, Labourier E, Lund G, Nielsen FC, Rodríguez-Ríos D, Solís-Martínez MO, Wrobel K, Wrobel K, Zaina S.

BMC Genomics. 2011 Nov 25;12:582. doi: 10.1186/1471-2164-12-582.

12.

Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR-ABL1 on the international reporting scale.

Brown JT, Laosinchai-Wolf W, Hedges JB, Watt CD, Van Deerlin VM, Fletcher L, Branford S, Labourier E.

Blood Cancer J. 2011 Mar;1(3):e13. doi: 10.1038/bcj.2011.10. Epub 2011 Mar 25.

13.

Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.

Laosinchai-Wolf W, Ye F, Tran V, Yang Z, White R, Bloom K, Choppa P, Labourier E.

J Clin Pathol. 2011 Jan;64(1):30-6. doi: 10.1136/jcp.2010.081539. Epub 2010 Oct 28.

PMID:
21030527
14.

Performance and clinical evaluation of a sensitive multiplex assay for the rapid detection of common NPM1 mutations.

Hafez M, Ye F, Jackson K, Yang Z, Karp JE, Labourier E, Gocke CD.

J Mol Diagn. 2010 Sep;12(5):629-35. doi: 10.2353/jmoldx.2010.090219. Epub 2010 Jul 8.

15.

International standards and reference materials for quantitative molecular infectious disease testing.

Madej RM, Davis J, Holden MJ, Kwang S, Labourier E, Schneider GJ.

J Mol Diagn. 2010 Mar;12(2):133-43. doi: 10.2353/jmoldx.2010.090067. Epub 2010 Jan 14. Review.

16.

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.

Szafranska AE, Doleshal M, Edmunds HS, Gordon S, Luttges J, Munding JB, Barth RJ Jr, Gutmann EJ, Suriawinata AA, Marc Pipas J, Tannapfel A, Korc M, Hahn SA, Labourier E, Tsongalis GJ.

Clin Chem. 2008 Oct;54(10):1716-24. doi: 10.1373/clinchem.2008.109603. Epub 2008 Aug 21.

17.

Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling.

Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, Labourier E.

J Mol Diagn. 2008 Sep;10(5):415-23. doi: 10.2353/jmoldx.2008.080018. Epub 2008 Aug 7.

18.

Asuragen Inc.

Labourier E, Winkler M.

Pharmacogenomics. 2008 Jun;9(6):675-80. doi: 10.2217/14622416.9.6.675.

19.

Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues.

Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, Szafranska AE.

J Mol Diagn. 2008 May;10(3):203-11. doi: 10.2353/jmoldx.2008.070153. Epub 2008 Apr 10.

20.

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.

Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA.

Oncogene. 2007 Jun 28;26(30):4442-52. Epub 2007 Jan 22.

PMID:
17237814
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk